CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
2022 · Journal of Experimental & Clinical Cancer Research · 39 citations
https://doi.org/10.1186/s13046-022-02362-w
L
Liming Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
225
Papers
3.4K
Citations
30
h-index
74
i10-index
Liming Xu is an academic researcher from Ankang University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Lung Cancer Research Studies & Lung Cancer Treatments and Mutations. The author has an h-index of 30, co-authored 192 publications.
ORCID: 0000-0001-9523-9062Papers by this author
worksConstruction and clinical evaluation of a new customized bite block used in radiotherapy of head and neck cancer
2019 · Cancer/Radiothérapie · 29 citations
https://doi.org/10.1016/j.canrad.2018.05.005
Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples
2020 · BMC Cancer · 27 citations
https://doi.org/10.1186/s12885-020-06851-z
Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study
2021 · ESMO Open · 25 citations
https://doi.org/10.1016/j.esmoop.2021.100206
Optimization of linkage mapping strategy and construction of a high-density American lotus linkage map
2014 · BMC Genomics · 20 citations
https://doi.org/10.1186/1471-2164-15-372
Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
2019 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-019-53003-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat